Advancing Epigenetics Towards Systems Biology

List of EpiGeneSys publications


Information is retrieved from

pubmed

Back to the index page

Group Leader:
Raffaella Santoro10 Publications.

2016

Identification of cis- and trans-acting elements regulating calretinin expression in mesothelioma cells.

Oncotarget 2016 Feb 1;

Kresoja-Rakic J, Kapaklikaya E, Ziltener G, Dalcher D, Santoro R, Christensen BC, Johnson KC, Schwaller B, Weder W, Stahel RA, Felley-Bosco E

View on PubMed

2015

Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.

Genome Biol 2015 Feb 22;16:42

Cheng PF, Shakhova O, Widmer DS, Eichhoff OM, Zingg D, Frommel SC, Belloni B, Raaijmakers MI, Goldinger SM, Santoro R, Hemmi S, Sommer L, Dummer R, Levesque MP

View on PubMed

Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.

PLoS Genet 2015 Jan;11(1):e1004877

Shakhova O, Cheng P, Mishra PJ, Zingg D, Schaefer SM, Debbache J, Häusel J, Matter C, Guo T, Davis S, Meltzer P, Mihic-Probst D, Moch H, Wegner M, Merlino G, Levesque MP, Dummer R, Santoro R, Cinelli P, Sommer L

View on PubMed

The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors.

Nat Commun 2015 Jan 22;6:6051

Zingg D, Debbache J, Schaefer SM, Tuncer E, Frommel SC, Cheng P, Arenas-Ramirez N, Haeusel J, Zhang Y, Bonalli M, McCabe MT, Creasy CL, Levesque MP, Boyman O, Santoro R, Shakhova O, Dummer R, Sommer L

View on PubMed

2014

BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence.

Nat Genet 2014 Dec 8;

Gu L, Frommel SC, Oakes CC, Simon R, Grupp K, Gerig CY, Bär D, Robinson MD, Baer C, Weiss M, Gu Z, Schapira M, Kuner R, Sültmann H, Provenzano M, ICGC Project on Early Onset Prostate Cancer, Yaspo ML, Brors B, Korbel J, Schlomm T, Sauter G, Eils R, Plass C, Santoro R

View on PubMed

lncRNA Maturation to Initiate Heterochromatin Formation in the Nucleolus Is Required for Exit from Pluripotency in ESCs.

Cell Stem Cell 2014 Dec 4;15(6):720-34

Savić N, Bär D, Leone S, Frommel SC, Weber FA, Vollenweider E, Ferrari E, Ziegler U, Kaech A, Shakhova O, Cinelli P, Santoro R

View on PubMed

DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells.

Mol Cancer 2014 May 27;13(1):125

Bachmann SB, Frommel SC, Camicia R, Winkler HC, Santoro R, Hassa PO

View on PubMed

ARTD2 activity is stimulated by RNA.

Nucleic Acids Res 2014 Feb 8;

Léger K, Bär D, Savic N, Santoro R, Hottiger MO

View on PubMed

2013

Analysis of Chromatin Composition of Repetitive Sequences: The ChIP-Chop Assay.

Methods Mol Biol 2014;1094:319-28

Santoro R

View on PubMed

The expanding role of PARPs in the establishment and maintenance of heterochromatin.

FEBS J 2013 Aug;280(15):3508-18

Dantzer F, Santoro R

View on PubMed

Latest publications

2017-06-27

The Histone Acetyltransferase Mst2 Protects Active Chromatin from Epigenetic Silencing by Acetylating the Ubiquitin Ligase Brl1.

Read more
2017-05-26

Proliferation Drives Aging-Related Functional Decline in a Subpopulation of the Hematopoietic Stem Cell Compartment.

Read more
2017-04-30

The impact of rare and low-frequency genetic variants in common disease.

Read more